Galectin Therapeutics (PHPN.F) Q3 2025 Earnings

14AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-0.19
-0.16
-0.13
-0.1

Details

Expected EPS
-0.1373376
Actual EPS
-0.1030032
Surprise EPS
0.03
Surprise Percent
+25%

Description

Galectin Therapeutics (PHPN.F) has reported earnings of -0.1030032 per share for Q3 2025.

0 Comments

Share your thoughts